The “Kick, Kill” study is planned to be conducted by the HIV research team at
Aarhus University Hospital, led by Prof. Lars Østergaard. Prof. Østergaard
presented the background and expectations of the study at Bionor Pharma’s
Capital Markets Day in June.
To read more, please visit the Bionor Pharma website.